Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra.

Literature DB >> 17998217

Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra.

D McGonagle, A L Tan, S Shankaranarayana, J Madden, P Emery, M F McDermott.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2007 PMID： 17998217 PMCID： PMC2095323 DOI： 10.1136/ard.2007.073759

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

10 in total

1. Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor alpha as a new therapeutic option.

Authors: A K Tausche; K Richter; A Grässler; S Hänsel; B Roch; H E Schröder
Journal: Ann Rheum Dis Date: 2004-10 Impact factor: 19.103

Review 2. Recent advances in crystal-induced acute inflammation.

Authors: Tohru Akahoshi; Yousuke Murakami; Hidero Kitasato
Journal: Curr Opin Rheumatol Date: 2007-03 Impact factor: 5.006

3. Mechanisms of benzarone and benzbromarone-induced hepatic toxicity.

Authors: Priska Kaufmann; Michael Török; Anya Hänni; Paul Roberts; Rodolfo Gasser; Stephan Krähenbühl
Journal: Hepatology Date: 2005-04 Impact factor: 17.425

4. Transformation of epithelial cells stably transfected with H2O2-generating peroxisomal urate oxidase.

Authors: R Chu; Y Lin; K C Reddy; J Pan; M S Rao; J K Reddy; A V Yeldandi
Journal: Cancer Res Date: 1996-11-01 Impact factor: 12.701

5. Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience.

Authors: C H Pui
Journal: Semin Hematol Date: 2001-10 Impact factor: 3.851

6. Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1.

Authors: F S Di Giovine; S E Malawista; G Nuki; G W Duff
Journal: J Immunol Date: 1987-05-15 Impact factor: 5.422

7. Gout-associated uric acid crystals activate the NALP3 inflammasome.

Authors: Fabio Martinon; Virginie Pétrilli; Annick Mayor; Aubry Tardivel; Jürg Tschopp
Journal: Nature Date: 2006-01-11 Impact factor: 49.962

8. Inhibition of monosodium urate monohydrate crystal-induced acute inflammation by retrovirally transfected prostaglandin D synthase.

Authors: Yousuke Murakami; Tohru Akahoshi; Izumi Hayashi; Hirahito Endo; Atsushi Hashimoto; Shizuka Kono; Hirobumi Kondo; Shinichi Kawai; Matsuhisa Inoue; Hidero Kitasato
Journal: Arthritis Rheum Date: 2003-10

9. Crystal-neutrophil interactions lead to interleukin-1 synthesis.

Authors: C J Roberge; J Grassi; R De Médicis; Y Frobert; A Lussier; P H Naccache; P E Poubelle
Journal: Agents Actions Date: 1991-09

10. A pilot study of IL-1 inhibition by anakinra in acute gout.

Authors: Alexander So; Thibaut De Smedt; Sylvie Revaz; Jürg Tschopp
Journal: Arthritis Res Ther Date: 2007 Impact factor: 5.156

10 in total

53 in total

Review 1. Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.

Authors: R Goldbach-Mansky
Journal: Clin Exp Immunol Date: 2012-03 Impact factor: 4.330

Review 2. Blockade of interleukin 1 in type 1 diabetes mellitus.

Authors: Thomas Mandrup-Poulsen; Linda Pickersgill; Marc Yves Donath
Journal: Nat Rev Endocrinol Date: 2010-03 Impact factor: 43.330

Review 3. Unleashing the therapeutic potential of NOD-like receptors.

Authors: Kaoru Geddes; João G Magalhães; Stephen E Girardin
Journal: Nat Rev Drug Discov Date: 2009-06 Impact factor: 84.694

Review 4. How metabolism generates signals during innate immunity and inflammation.

Authors: Anne F McGettrick; Luke A J O'Neill
Journal: J Biol Chem Date: 2013-06-24 Impact factor: 5.157

5. [Recommendations on therapy using interleukin-1beta-blocking agents].

Authors: B Manger; M Gaubitz; H Michels
Journal: Z Rheumatol Date: 2009-11 Impact factor: 1.372

Review 6. Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses.

Authors: Raphaela Goldbach-Mansky; Daniel L Kastner
Journal: J Allergy Clin Immunol Date: 2009-12 Impact factor: 10.793